Publication: 2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies
Loading...
Files
Program
relationships.isAuthorOf
Author
Qayed W. S.
Hassan M. A.
Şenol H.
Taslimi P.
Aboul-Fadl T.
Advisor
Date
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Source
Keywords
Keywords
Eczacılık , Meslek Bilimleri , Farmasötik Kimya , Sağlık Bilimleri , Pharmacology and Therapeutics , Professional Sciences , Pharmaceutical Chemistry , Health Sciences , Klinik Tıp (Med) , Yaşam Bilimleri (Life) , Farmakoloji ve Toksikoloji , Farmakoloji ve Eczacılık , Clinical Medicine (Med) , Life Sciences (Life) , Pharmacology & Toxicology , Pharmacology & Pharmacy , Farmakoloji , Farmakoloji, Toksikoloji ve Eczacılık (çeşitli) , Genel Farmakoloji, Toksikoloji ve Eczacılık , Farmakoloji (tıbbi) , İlaç Rehberleri , Yaşam Bilimleri , Pharmacy , Pharmacology , Pharmacology, Toxicology and Pharmaceutics (miscellaneous) , General Pharmacology, Toxicology and Pharmaceutics , Pharmacology (medical) , Drug Guides , Life Sciences
Citation
Qayed W. S., Hassan M. A., Şenol H., Taslimi P., Aboul-Fadl T., "2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies", RSC MEDICINAL CHEMISTRY, cilt.16, sa.11, ss.1-25, 2025